Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer

E. Barnard, S. Patrick, D. Fairely, M. Catherwood, L. Martin, D. O'Rourke, A. McDowell

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    Abstract

    Recent studies suggest that P. acnes may be a frequent coloniser of prostate tissue, where it is associated with acute and chronic inflammatory changes which could potentially stimulate carcinogenesis. Culture methods for P. acnes detection are sub-optimal due to the slow growth of the organism coupled with the lack of sensitivity of end-point PCR, therefore, we have developed a novel quantitative TaqMan qPCR assay to detect and quantify Propionibacterium acnes in cancerous prostate tissue. Our developed assay employs the use of primers that target Propionibacterium specific regions of the 16S rRNA gene, in combination with the TaqMan probe which was designed to hybridise with P. acnes sequences only. PCR inhibition was eliminated using an established human endogenous retrovirus-3 assay which quantifies human cells present in clinical samples and simultaneously provides normalisation of the P. acnes genome count. DNA from a range of bacterial species was used to assess specificity of the assay. The assay was applied to DNA extracted from archived tissue specimens retrieved from prostate cancer patients in the UK. Archived prostate tissue from disease-free patients and non-prostatic tissue controls were compared. Our studies confirm the presence of P. acnes DNA in the prostate tissue of UK patients and reveal levels in cancerous prostates significantly higher than those found in control tissue (p
    LanguageEnglish
    Title of host publicationUnknown Host Publication
    Pages169-169
    Number of pages1
    Publication statusPublished - Jun 2012
    EventAnaerobe 2012; 11th Biennial Congress of the Society of the Americas - San Francisco, CA
    Duration: 1 Jun 2012 → …

    Conference

    ConferenceAnaerobe 2012; 11th Biennial Congress of the Society of the Americas
    Period1/06/12 → …

    Fingerprint

    Propionibacterium
    Prostatic Neoplasms
    Propionibacterium acnes
    Polymerase Chain Reaction
    Prostate
    Acne Vulgaris
    DNA
    Endogenous Retroviruses
    rRNA Genes
    Carcinogenesis
    Genome
    Growth

    Cite this

    Barnard, E., Patrick, S., Fairely, D., Catherwood, M., Martin, L., O'Rourke, D., & McDowell, A. (2012). Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer. In Unknown Host Publication (pp. 169-169)
    Barnard, E. ; Patrick, S. ; Fairely, D. ; Catherwood, M. ; Martin, L. ; O'Rourke, D. ; McDowell, A. / Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer. Unknown Host Publication. 2012. pp. 169-169
    @inproceedings{809f8c782a70431f8866d00e494e393f,
    title = "Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer",
    abstract = "Recent studies suggest that P. acnes may be a frequent coloniser of prostate tissue, where it is associated with acute and chronic inflammatory changes which could potentially stimulate carcinogenesis. Culture methods for P. acnes detection are sub-optimal due to the slow growth of the organism coupled with the lack of sensitivity of end-point PCR, therefore, we have developed a novel quantitative TaqMan qPCR assay to detect and quantify Propionibacterium acnes in cancerous prostate tissue. Our developed assay employs the use of primers that target Propionibacterium specific regions of the 16S rRNA gene, in combination with the TaqMan probe which was designed to hybridise with P. acnes sequences only. PCR inhibition was eliminated using an established human endogenous retrovirus-3 assay which quantifies human cells present in clinical samples and simultaneously provides normalisation of the P. acnes genome count. DNA from a range of bacterial species was used to assess specificity of the assay. The assay was applied to DNA extracted from archived tissue specimens retrieved from prostate cancer patients in the UK. Archived prostate tissue from disease-free patients and non-prostatic tissue controls were compared. Our studies confirm the presence of P. acnes DNA in the prostate tissue of UK patients and reveal levels in cancerous prostates significantly higher than those found in control tissue (p",
    author = "E. Barnard and S. Patrick and D. Fairely and M. Catherwood and L. Martin and D. O'Rourke and A. McDowell",
    year = "2012",
    month = "6",
    language = "English",
    pages = "169--169",
    booktitle = "Unknown Host Publication",

    }

    Barnard, E, Patrick, S, Fairely, D, Catherwood, M, Martin, L, O'Rourke, D & McDowell, A 2012, Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer. in Unknown Host Publication. pp. 169-169, Anaerobe 2012; 11th Biennial Congress of the Society of the Americas, 1/06/12.

    Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer. / Barnard, E.; Patrick, S.; Fairely, D.; Catherwood, M.; Martin, L.; O'Rourke, D.; McDowell, A.

    Unknown Host Publication. 2012. p. 169-169.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    TY - GEN

    T1 - Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer

    AU - Barnard, E.

    AU - Patrick, S.

    AU - Fairely, D.

    AU - Catherwood, M.

    AU - Martin, L.

    AU - O'Rourke, D.

    AU - McDowell, A.

    PY - 2012/6

    Y1 - 2012/6

    N2 - Recent studies suggest that P. acnes may be a frequent coloniser of prostate tissue, where it is associated with acute and chronic inflammatory changes which could potentially stimulate carcinogenesis. Culture methods for P. acnes detection are sub-optimal due to the slow growth of the organism coupled with the lack of sensitivity of end-point PCR, therefore, we have developed a novel quantitative TaqMan qPCR assay to detect and quantify Propionibacterium acnes in cancerous prostate tissue. Our developed assay employs the use of primers that target Propionibacterium specific regions of the 16S rRNA gene, in combination with the TaqMan probe which was designed to hybridise with P. acnes sequences only. PCR inhibition was eliminated using an established human endogenous retrovirus-3 assay which quantifies human cells present in clinical samples and simultaneously provides normalisation of the P. acnes genome count. DNA from a range of bacterial species was used to assess specificity of the assay. The assay was applied to DNA extracted from archived tissue specimens retrieved from prostate cancer patients in the UK. Archived prostate tissue from disease-free patients and non-prostatic tissue controls were compared. Our studies confirm the presence of P. acnes DNA in the prostate tissue of UK patients and reveal levels in cancerous prostates significantly higher than those found in control tissue (p

    AB - Recent studies suggest that P. acnes may be a frequent coloniser of prostate tissue, where it is associated with acute and chronic inflammatory changes which could potentially stimulate carcinogenesis. Culture methods for P. acnes detection are sub-optimal due to the slow growth of the organism coupled with the lack of sensitivity of end-point PCR, therefore, we have developed a novel quantitative TaqMan qPCR assay to detect and quantify Propionibacterium acnes in cancerous prostate tissue. Our developed assay employs the use of primers that target Propionibacterium specific regions of the 16S rRNA gene, in combination with the TaqMan probe which was designed to hybridise with P. acnes sequences only. PCR inhibition was eliminated using an established human endogenous retrovirus-3 assay which quantifies human cells present in clinical samples and simultaneously provides normalisation of the P. acnes genome count. DNA from a range of bacterial species was used to assess specificity of the assay. The assay was applied to DNA extracted from archived tissue specimens retrieved from prostate cancer patients in the UK. Archived prostate tissue from disease-free patients and non-prostatic tissue controls were compared. Our studies confirm the presence of P. acnes DNA in the prostate tissue of UK patients and reveal levels in cancerous prostates significantly higher than those found in control tissue (p

    M3 - Conference contribution

    SP - 169

    EP - 169

    BT - Unknown Host Publication

    ER -

    Barnard E, Patrick S, Fairely D, Catherwood M, Martin L, O'Rourke D et al. Application of a novel quantitative-PCR assay to investigate the role of Propionibacterium in the aetiology of prostate cancer. In Unknown Host Publication. 2012. p. 169-169